SBUX
NFLX EPS: $0.49 versus $0.40 estimate
Results 1 to 3 of 3
SBUX
NFLX EPS: $0.49 versus $0.40 estimate
Theravance says the FDA's Pulmonary-Allergy Drugs Advisory Committee will discuss the company's NDA for the COPD treatment Anoro Ellipta on September 10.
National Cinemedia beats by $0.01, beats on revenue